ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

The Pristine Post-Market Study

ClinicalTrials.gov ID: NCT05228132

Public ClinicalTrials.gov record NCT05228132. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multi-Center, Single-Arm Clinical Study of the Pristine™ Long-Term Hemodialysis Catheter

Study identification

NCT ID
NCT05228132
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
C. R. Bard
Industry
Enrollment
142 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 15, 2022
Primary completion
Sep 20, 2022
Completion
Sep 20, 2022
Last update posted
Apr 10, 2024

2022

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Trinity Research Group LLC Dothan Alabama 36301
Yale University New Haven Connecticut 06520
Louisiana State University Health Shreveport Medical Center Shreveport Louisiana 71103
Henry Ford Health System Detroit Michigan 48202
North Carolina Nephrology, PA Raleigh North Carolina 27610
JML Research Associates Providence Rhode Island 02906

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05228132, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05228132 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →